Provide the student with information on 1) principles and limits of gene therapy, 2) approaches and types of vectors, 3) notes on non-viral vectors, 4) gene editing (CRISPR/Cas9), 5) main viral vectors, advantages and disadvantages, 6) examples of clinical trials based on gene therapy, disappointments and hopes, 7) current and future perspectives. Upon completion of the course, students will have acquired the knowledge necessary to understand how viruses can be engineered and used as therapeutic agents (vectors for gene therapy , oncolytic viruses).
Gene therapy: • Introduction to gene therapy • Non-viral vectors, siRNA and miRNA, peptide vectors • Gene editing: ZFN, TALEN, Crispr/Cas9 • Viral vectors, general information • Adenovirus (AV) • Adeno-associated virus (AAV) • Vectors herpes and poxviruses • Retroviral and lentiviral vectors • Clinical trials: hematological, metabolic, neurodegenerative, neuromuscular and dystrophies diseases, cystic fibrosis • Anti-tumor gene therapy, oncolytic viruses
Not expected
© 2002 - 2024
Verona University
Via dell'Artigliere 8, 37129 Verona |
P. I.V.A. 01541040232 |
C. FISCALE 93009870234